Celularity, Inc. (CELU)
0.7748
-0.03
(-3.16%)
USD |
NASDAQ |
Aug 24, 16:00
0.7719
0.00 (0.00%)
After-Hours: 20:00
Celularity Shareholders Equity (Quarterly) : -38.06M for Dec. 31, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2025 | -38.06M |
| September 30, 2025 | -20.09M |
| June 30, 2025 | -25.50M |
| March 31, 2025 | -5.506M |
| December 31, 2024 | 8.837M |
| September 30, 2024 | 17.28M |
| June 30, 2024 | 27.81M |
| March 31, 2024 | 31.24M |
| December 31, 2023 | 40.96M |
| September 30, 2023 | 30.25M |
| June 30, 2023 | 118.50M |
| March 31, 2023 | 155.63M |
| December 31, 2022 | 198.90M |
| September 30, 2022 | 164.24M |
| Date | Value |
|---|---|
| June 30, 2022 | 150.15M |
| March 31, 2022 | 89.90M |
| December 31, 2021 | 99.42M |
| September 30, 2021 | 96.22M |
| June 30, 2021 | 80.96M |
| March 31, 2021 | -61.82M |
| December 31, 2020 | 18.71M |
| September 30, 2020 | 281.41M |
| June 30, 2020 | 281.44M |
| March 31, 2020 | |
| December 31, 2019 | 263.39M |
| September 30, 2019 | 279.81M |
| June 30, 2019 | 278.69M |
| March 31, 2019 | -0.1436M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Tenax Therapeutics, Inc. | 113.59M |
| Exicure, Inc. | 0.977M |
| Century Therapeutics, Inc. | 232.34M |
| Absci Corp. | 246.13M |
| Cardio Diagnostics Holdings, Inc. | 7.426M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 302.90M |
| Total Liabilities (Quarterly) | 340.96M |
| Debt to Equity Ratio | -1.963 |
| Current Ratio | 0.1525 |
| Net Debt Paydown Yield | -3.53% |